Track topics on Twitter Track topics that are important to you
* Has signed an agreement with DM Bio for development and sale of biosimilar medicine trastuzumab.
Original Article: BRIEF-Richter signs deal with DM Bio for biosimilar cancer medicineNEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...